rs201727231
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_001083614.2(EARS2):c.1547G>A(p.Arg516Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000768 in 1,614,048 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000076 ( 0 hom. )
Consequence
EARS2
NM_001083614.2 missense
NM_001083614.2 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 4.96
Genes affected
EARS2 (HGNC:29419): (glutamyl-tRNA synthetase 2, mitochondrial) This gene encodes a member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of glutamate to tRNA molecules. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency 12 (COXPD12). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.83
PP5
Variant 16-23524396-C-T is Pathogenic according to our data. Variant chr16-23524396-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 265109.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=1, Pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EARS2 | NM_001083614.2 | c.1547G>A | p.Arg516Gln | missense_variant | 9/9 | ENST00000449606.7 | NP_001077083.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EARS2 | ENST00000449606.7 | c.1547G>A | p.Arg516Gln | missense_variant | 9/9 | 1 | NM_001083614.2 | ENSP00000395196 | P1 | |
EARS2 | ENST00000564987.1 | n.1191G>A | non_coding_transcript_exon_variant | 8/9 | 1 | |||||
EARS2 | ENST00000674054.1 | c.1547G>A | p.Arg516Gln | missense_variant, NMD_transcript_variant | 9/10 | ENSP00000501251 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152174Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
13
AN:
152174
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000641 AC: 16AN: 249576Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135404
GnomAD3 exomes
AF:
AC:
16
AN:
249576
Hom.:
AF XY:
AC XY:
8
AN XY:
135404
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000759 AC: 111AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000715 AC XY: 52AN XY: 727240
GnomAD4 exome
AF:
AC:
111
AN:
1461874
Hom.:
Cov.:
32
AF XY:
AC XY:
52
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152174Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74340
GnomAD4 genome
AF:
AC:
13
AN:
152174
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 14, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Washington University in St. Louis | Oct 23, 2023 | The EARS2 c.1547G>A (p.Arg516Gln) variant has been reported in two individuals affected with Leukoencephalopathy-Thalamus And Brainstem Anomalies-High Lactate Syndrome (Roux CJ et al., PMID: 33972171; Steenweg ME et al., PMID: 22492562). One patient was compound heterozygous for c.1547G>A and a different pathogenic variant (Steenweg ME et al., PMID: 22492562). The highest population minor allele frequency in the population database genome aggregation database (v.2.1.1) is 0.015% in European-non Finnish population. Another variant affecting codon 516, c.1546C>T (p.Arg516Trp), has been reported as pathogenic in two affected brothers (Sahin S et al., PMID: 27206875). An additional variant affecting codon 516, c.1546C>G (p.Arg516Gly), is reported in ClinVar as a variant of uncertain significance (ClinVar Variation ID: 134876). Computational predictors are uncertain as to the impact of this variant on EARS2 function. This variant has been reported in the ClinVar database as pathogenic, likely pathogenic and as a variant of uncertain significance (ClinVar Variation ID:265109). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. - |
See cases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Personalized Medicine, Children's Hospital Los Angeles | Dec 21, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2015 | The R516Q variant has been previously published in association with leukoencephalopathy with thalmus and brainstem involvement and high lactate (LTBL) in a patient who was compound heterozygous for the two mutations (Steenweg et al., 2012). This patient was described as having a severe phenotype with hypotonia, impaired psychomotor development, dystonia, vision problems, elevated lactate, and seizures (Steenweg et al., 2012). The R516Q variant is a non-conservative amino acid substitution of a positively charged residue with an uncharged residue. We interpret this variant as pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 18, 2023 | Variant summary: EARS2 c.1547G>A (p.Arg516Gln) results in a conservative amino acid change located in the Aminoacyl-tRNA synthetase, class I, anticodon-binding domain (IPR045462) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 249576 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1547G>A has been reported in the literature in compound heterozygous individuals affected with Leukoencephalopathy-Thalamus And Brainstem Anomalies-High Lactate Syndrome (e.g., Steenweg_2012, Roux_2021). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33128823, 33972171, 22492562). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic (n = 1) or likely pathogenic (n = 2). Additionally, another missense variant affecting the same amino acid, c.1546C>T (p.Arg516Trp), has been reported in the literature in patients affected with Leukoencephalopathy-Thalamus And Brainstem Anomalies-High Lactate Syndrome (PMID: 27206875). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at